| 摘要: |
| 目的:了解四川地区抗肿瘤药物风险分级现状及需求,以构建抗肿瘤药物风险提示系统,提高抗肿瘤药物临床应用的安
全性和有效性。方法:采用调查问卷了解四川地区抗肿瘤药物风险分级现状及需求。结果:受访医务人员所在医院的抗肿瘤药
物使用现状:63. 29%存在抗肿瘤药物的超说明书用药,77. 22%有抗肿瘤药物处方前置审核系统,82. 28%为一线医师开具抗肿
瘤药物处方需要上级医师审核,91. 14%为配置静脉用抗肿瘤药物使用生物安全柜,86. 08%为医务人员在配置抗肿瘤药物时穿
戴防护用具,78. 48%为抗肿瘤药物高危标识嵌入电子信息系统,81. 01%有抗肿瘤药物的分级管理制度,81. 01%有抗肿瘤药物
分级管理目录;受访医务人员对抗肿瘤药物的风险因素及风险防范的认知程度一般,而医师、护士和药师对抗肿瘤药物风险点
的风险程度认知有所不同;受访医务人员希望构建抗肿瘤药物风险提示系统并建议了相关影响因素的重要性。结论:四川地区
抗肿瘤药物风险分级现状较好,受访医务人员对肿瘤药物的风险因素及风险防范的认知程度侧重于其工作岗位,强烈要求构建
抗肿瘤药物风险提示系统。 |
| 关键词: 抗肿瘤药物 风险分级 医务人员 |
| DOI：doi:10.13407/j.cnki.jpp.1672-108X.2023.02.002 |
|
| 基金项目:国家卫生计生委项目,编号FHTA2019-03。 |
|
| Study on the Current Status and Demand of Risk Classification of Antineoplastic Drugs in Sichuan |
| Yang Chunsong, Yang Yaya, Lin Yunzhu, Zhang Lingli |
| ((West China Second Hospital, Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu 610041, China) |
| Abstract: |
| Objective: To understand the current situation and demand of risk classification of antineoplastic drugs in Sichuan, so as to
establish a risk warning system for antineoplastic drugs, and improve the safety and effectiveness of clinical application of antineoplastic
drugs. Methods: Questionnaires were used to investigate the current status and demand of risk classification of antineoplastic drugs in
Sichuan. Results: The current situation of the use of antineoplastic drugs in the hospitals of the surveyed medical staff was as follows:
63. 29% had the off-line use of antineoplastic drugs, 77. 22% had the pre-approval system for antineoplastic drugs prescription, 82. 28%
needed the approval of superior doctors for the prescription of antineoplastic drugs for first-line doctors, 91. 14% had the biosafety cabinet
for the use of intravenous antineoplastic drugs, 86. 08% of the medical staff wore protective equipment when dispensing antineoplastic
drugs, 78. 48% of the high risk identification of antineoplastic drugs was embedded in the electronic information system, 81. 01% had
the classification management system of antineoplastic drugs, and 81. 01% had the classification management catalog of antineoplastic
drugs. The cognition degree of risk factors and risk prevention of antineoplastic drugs was average among the surveyed medical staff,
while the cognition degree of risk points of antineoplastic drugs was different among doctors, nurses and pharmacists. The surveyed
medical staff hoped to build a risk warning system for antineoplastic drugs and suggested the importance of related influencing factors.
Conclusion: The current status of risk classification of antineoplastic drugs in Sichuan province is good. The cognition degree of the
surveyed medical staff on the risk factors and risk prevention of antineoplastic drugs focuses on their work positions, and they strongly
require the construction of antineoplastic drug risk warning system. |
| Key words: antineoplastic drug risk classification medical staff |
